Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. - Wikidata - wikimedia - TriplyDB

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

http://www.wikidata.org/entity/Q37449181

about

Adjuvant therapy for resected pancreatic cancer Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus Feeding Challenges in Patients with Esophageal and Gastroesophageal Cancers Neoadjuvant therapy for gastroesophageal adenocarcinoma Cervical esophageal cancer: a gap in cancer knowledge Emerging therapeutic targets in esophageal adenocarcinoma Definitive, Preoperative, and Palliative Radiation Therapy of Esophageal Cancer Systematic review and network meta-analysis: neoadjuvant chemoradiotherapy for locoregional esophageal cancer Treatment of esophagogastric junction carcinoma: an unsolved debate The role of induction therapy Clinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approach Novel immunotherapeutic strategies of gastric cancer treatment Neoadjuvant Therapy of Gastric Cancer: A Decisive Step Forward Radiation therapy and esophageal cancer Preoperative therapy in locally advanced esophageal cancer Advances in Radiotherapy Management of Esophageal Cancer Reevaluation of Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma: A Meta-Analysis of Randomized Controlled Trials Over the Past 20 Years Locally advanced gastroesophageal junction tumor: a treatment dilemma Local treatment of hand-foot syndrome with uridine/thymidine: in vitro appraisal on a human keratinocyte cell line HaCaT Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus Current Advancement in Multidisciplinary Treatment for Resectable cStage II/III Esophageal Squamous Cell Carcinoma in Japan.Comparison of neoadjuvant versus a surgery first approach for gastric and esophagogastric cancer.Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.Utilization of surgical treatment for local and locoregional esophageal cancer: Analysis of the National Cancer Data Base.Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer.Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction A retrospective study of californium-252 neutron brachytherapy combined with EBRT versus 3D-CRT in the treatment of esophageal squamous cell cancer.Recent advances in preoperative management of esophageal adenocarcinoma Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database.Stereotactic radiotherapy in the treatment of local recurrences of esophageal cancer High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett's carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy Survival comparison between radical surgery and definitive chemoradiation in 267 esophageal squamous cell carcinomas in a single institution: A propensity-matched study.Esophageal cancer: staging system and guidelines for staging and treatment.Does the timing of esophagectomy after chemoradiation affect outcome?ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS).Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma-a pilot study.Outcome of proximal esophageal cancer after definitive combined chemo-radiation: a Swiss multicenter retrospective study Current strategies in chemoradiation for esophageal cancer.

P2860

Q24186323-8130F60F-7473-4894-A4BC-CB2F30FC3E90 Q24202957-3037F6B6-61F3-486D-A19F-860D97C98872 Q26741107-2E82969D-0F97-434A-BA68-0866238C1AC2 Q26746147-5DD78C34-D337-45AB-ABF7-2EC34CD87490 Q26749536-558025EF-878B-4200-A25D-CE16A45CEB78 Q26751209-1FEBD9E8-6959-4063-A4F4-8CA7E3BB01CF Q26753864-4AF93ACF-4819-4A37-B07C-771795158CA0 Q26798301-1CBA587C-5654-493A-BE11-74200A12082F Q26827179-AC08341D-E70D-42D9-B8C4-04CB58A406A5 Q26830698-0DED1DC2-7B2F-4516-B90F-D5E74624B834 Q26862365-E7696120-D265-447C-BC30-A8E00EC28654 Q27011232-70F6930B-AEDD-41E1-925A-1224D6A43343 Q27016030-7E57391E-551B-47DB-91ED-66DC08EC8BD3 Q27026922-26C84A64-55B4-4B2A-BE27-D4CB98444487 Q28070310-F7730306-CA6E-4812-8AA1-E593F84276FC Q28078750-19161962-9DB9-4689-8FDB-D8EF1CEC4A57 Q28081365-49DBFB63-F79C-41D0-9BBE-0A0A311BFC95 Q28082596-04C4C7E7-40B5-4646-A2E4-D7DBDAB319F3 Q28273580-3F79DFBD-99FF-4242-9D05-EC2C5866CC0F Q28391760-7EBD219D-D409-45C1-8FE8-91528A56FF8C Q30244382-0ABDAF59-3711-4E54-BF30-E0AF78DAD93D Q30248541-9402D8B5-4C33-4EDC-89AF-0CD8011ADECE Q30538788-C2BD478D-4B28-45F8-A9A3-C7FC67F6879E Q31133579-98FA28D5-35C8-48A3-A645-A08BD36C32DB Q33387427-AA256FAE-52FA-4882-9FA8-21C25577084F Q33400021-909E1BBD-DBC8-4AB9-9FE0-CE23C35C5F8C Q33422992-83E35F4F-DEC9-40F2-A9FA-682D3F716ACF Q33427016-8BA770F1-3283-4281-A183-A2DB810AECC6 Q33589301-007E6070-1AA9-43C3-B6F9-80A31A44D5F4 Q33598288-B2C83C4C-9896-4BEA-A3AA-A4A7230BC058 Q33598596-FA16628A-8C91-4FB8-BCD8-47ACB1AE9B0E Q33633596-542963AD-6A6C-4CA9-B5D2-87D624E62E48 Q33648496-CF616910-6379-4490-9DC1-F78A0D78A36B Q33653046-B45FE6A5-BFA1-470D-BC00-32808EA8AD68 Q33680811-09F500FA-0332-41C2-B2D4-91BDB5485992 Q33699376-9BCF05C7-1167-4030-9408-105E804F9463 Q33759688-798AA272-694F-4175-8414-F85671A36B10 Q33763860-7E6A07D1-BAC3-4CAE-B26D-58DFD64BBCBD Q33795763-837B0816-C62A-4B8B-BF30-BD6A26F0A57B Q33820782-D166AC78-7EF4-488F-BB53-CF1308C6D2D4

P2860

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

http://www.wikidata.org/entity/Q37449181

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Phase III trial of trimodality ...... esophageal cancer: CALGB 9781.

@en

Phase III trial of trimodality ...... esophageal cancer: CALGB 9781.

@nl

type

label

Phase III trial of trimodality ...... esophageal cancer: CALGB 9781.

@en

Phase III trial of trimodality ...... esophageal cancer: CALGB 9781.

@nl

prefLabel

Phase III trial of trimodality ...... esophageal cancer: CALGB 9781.

@en

Phase III trial of trimodality ...... esophageal cancer: CALGB 9781.

@nl

P1433

Q37449181-7A47FA2F-F4D7-4355-9A86-CE83F9BB3835

P1476

Q37449181-A3B2996B-4DD2-474E-83E2-79AFD09D8497

P2093

Q37449181-2B61957F-57E0-4D4D-BCE8-1628CBD8E1DA

Q37449181-47E34C0A-BDFF-4423-A208-B7DC5CB598B8

Q37449181-4BD31DAC-1508-4629-82F2-5C1AC3FB3BC6

Q37449181-537821EF-9C85-4CDD-9A0F-6E5D72863624

Q37449181-692B3A7F-C8B1-44E9-82DF-F661CA9FC0F3

Q37449181-AC34A836-EF76-44E5-9E49-D90B7D483B8C

Q37449181-D639D0D7-6C65-4BB2-88D5-BF2C850CC702

Q37449181-E7BCC338-5DE6-4CE0-8681-ED94D7F8045F

Q37449181-FB86CDEE-665C-4BB0-B1F2-C9A67E19038C

P2860

Q37449181-0E94B289-7A80-4B0F-8881-D1BEA474A0E7

Q37449181-10843300-F212-41DB-99F8-8E3F9820F1F5

Q37449181-22B0AF45-000C-4641-89BD-6A628F56DF4E

Q37449181-2F8F9890-83CC-441E-882D-743DEDF1E8BF

Q37449181-4C581265-B426-4FC8-81AD-90674417F447

Q37449181-5026B487-51ED-4DAD-9364-47E8F38FB2DF

Q37449181-5543BF4C-78ED-4894-9ADB-C95EF0D9235B

Q37449181-7198269C-790F-4F82-AF36-1FD2454C5913

Q37449181-A325E497-8C82-481C-A1B3-56223932FFDC

Q37449181-B7093FD3-D350-40A1-AF6F-381072185563

P304

Q37449181-CCBFA0CA-6F89-463D-95F4-389A49BE902B

P31

Q37449181-7C07A825-B90B-44B1-A8E5-79E30DB489C1

P356

Q37449181-229948B1-3E1E-45A9-94F5-B51381CDB133

P407

Q37449181-5F2A997D-CAD2-48D0-9F4A-F9BA8D7173CE

P433

Q37449181-DC6A291A-EF87-45F2-8991-B784DD8153B6

P478

Q37449181-01E6545B-DF09-450D-AA24-08F92B0E85D2

P50

Q37449181-E77E6FFA-6114-48AE-8837-681F84749BDF

P577

Q37449181-507836A5-4938-4DE5-BBD1-7121E9006A0C

P698

Q37449181-DDBFAC49-8E7F-4E03-A5C4-0C384A07D655

P921

Q37449181-455608B6-54E6-4ACB-AC89-1B2CB43A46D3

Q37449181-74D04D8E-5197-42C8-85E6-5DAF89FFBFB4

P932

Q37449181-F44831CC-3F0A-4DB3-88EE-3A270C78D062

P356

JCO.2007.12.9593

P1433

Journal of Clinical Oncology

P1476

Phase III trial of trimodality ...... esophageal cancer: CALGB 9781.

@en

P2093

Carolyn E Reed

http://www.w3.org/2001/XMLSchema#string

Christopher Willett

http://www.w3.org/2001/XMLSchema#string

Donna Hollis

http://www.w3.org/2001/XMLSchema#string

Donna Niedzwiecki

http://www.w3.org/2001/XMLSchema#string

Joel Tepper

http://www.w3.org/2001/XMLSchema#string

Krystyna Kiel

http://www.w3.org/2001/XMLSchema#string

Mark J Krasna

http://www.w3.org/2001/XMLSchema#string

Richard Goldberg

http://www.w3.org/2001/XMLSchema#string

Robert Mayer

http://www.w3.org/2001/XMLSchema#string

P2860

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

A multiple testing procedure for clinical trials

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.

A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.

Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis

Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis.

Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis.

Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma.

Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer.

P304

1086-1092

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2007.12.9593

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

David J. Sugarbaker

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18309943

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

phase III clinical trial

P932

5126644

http://www.w3.org/2001/XMLSchema#string